These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 8549297

  • 21. [Tosufloxacin tosilate].
    Shimada K.
    Jpn J Antibiot; 1990 Apr; 43(4):583-602. PubMed ID: 2199687
    [No Abstract] [Full Text] [Related]

  • 22. [Causes of quinolone resistance in gram-negative bacteria].
    Cullmann W.
    Immun Infekt; 1990 Jun; 18(3):80-8. PubMed ID: 2165997
    [Abstract] [Full Text] [Related]

  • 23. [Nationwide sensitivity surveillance of ciprofloxacin and various parenteral antibiotics against bacteria isolated from patients with severe infections--the first Ciproxan IV special investigation in 2001].
    Yamaguchi K, Ishii Y, Iinuma Y, Yamanaka K, Ichiyama S, Watanabe N, Uehara N, Kaku M, Kurokawa Y, Hayashi M, Hirakata Y.
    Jpn J Antibiot; 2003 Dec; 56(6):546-73. PubMed ID: 15007872
    [Abstract] [Full Text] [Related]

  • 24. Quinolone activity against anaerobes.
    Appelbaum PC.
    Drugs; 1999 Dec; 58 Suppl 2():60-4. PubMed ID: 10553708
    [Abstract] [Full Text] [Related]

  • 25. Prevention and control of resistance to the quinolones.
    Vellend H.
    Clin Invest Med; 1989 Feb; 12(1):74-5. PubMed ID: 2920485
    [No Abstract] [Full Text] [Related]

  • 26. Quinolone mode of action.
    Hooper DC.
    Drugs; 1995 Feb; 49 Suppl 2():10-5. PubMed ID: 8549276
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Pharmacodynamics of quinolones.
    Dalhoff A.
    Drugs; 1995 Feb; 49 Suppl 2():197-9. PubMed ID: 8549302
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The evolution of fluorinated quinolones: pharmacology, microbiological activity, clinical uses, and toxicities.
    Siporin C.
    Annu Rev Microbiol; 1989 Feb; 43():601-27. PubMed ID: 2679364
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Quinolone antibacterials. An update of their pharmacology and therapeutic use.
    von Rosenstiel N, Adam D.
    Drugs; 1994 Jun; 47(6):872-901. PubMed ID: 7521829
    [Abstract] [Full Text] [Related]

  • 35. Quinolone therapy in the management of infection after irradiation.
    Brook I, Ledney GD.
    Crit Rev Microbiol; 1992 Jun; 18(4):235-46. PubMed ID: 1524673
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. In vitro interaction between ofloxacin and cefotaxime against gram-positive and gram-negative bacteria involved in serious infections.
    Gimeno C, Borja J, Navarro D, Valdés L, García-Barbal J, García-de-Lomas J.
    Chemotherapy; 1998 Jun; 44(2):94-8. PubMed ID: 9551238
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.